Behavioral intervention to reduce sleep medication misuse in the elderly
Brief Intervention for Reducing Prolonged Use of Sleep Medication Among Elderly
This study is testing a new way for doctors to help older patients use sleep medications safely and reduce misuse compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog) |
| Trial ID | NCT06032715 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a behavioral Brief Intervention administered by trained general practitioners to reduce the misuse of Z-hypnotics among elderly patients in primary care. It is a randomized controlled trial with two arms: one receiving the intervention and the other receiving standard care. The study will assess outcomes at 6 weeks, with additional follow-ups at 6 months and 12 months to evaluate long-term effects. Baseline assessments will utilize self-reports and actigraphy to measure sleep patterns without bias.
Who should consider this trial
Good fit: Ideal candidates are elderly individuals who self-report using Z-hypnotics more than 4 days a week for over 4 weeks.
Not a fit: Patients with diagnoses of dementia, psychosis, major depression, or delirium will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce harmful use of sleep medications in the elderly, improving their overall health and cognitive function.
How similar studies have performed: Other studies have shown success with behavioral interventions for medication misuse, suggesting a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-reported use of Z-hypnotics \> 4 days per week and \> 4 weeks Exclusion Criteria: * diagnosis of dementia, * diagnosis of psychosis, * diagnosis of major depression, * diagnosis of delirium, * unable to give informed consent, * insufficient Norwegian language capacity to complete tests
Where this trial is running
Lørenskog
- Akershus University Hospital — Lørenskog, Norway (Recruiting)
Study contacts
- Study coordinator: Tahreem G Siddiqui, PhD
- Email: tahs@ahus.no
- Phone: 90600984
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.